Comparing two starting doses of follicle-stimulating hormone in IVF
Part of Women’s health & pregnancy clinical trials.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 34 years old or younger.
- Have a body mass index (BMI) between 18 and 25.
- Have a normal egg supply (ovarian reserve) as shown by an ultrasound count and a blood test (AMH).
- Be going through your very first IVF cycle.
- Use a specific type of IVF that includes injecting sperm directly into the egg (ICSI).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.